BUHLMANN News

Visit BUHLMANN at DDW 2017- Booth 1925

Digestive Diseases Week (DDW) 2017 BUHLMANN Diagnostics Corp Booth: #1925 May 06 - 09, 2017 | McCormick Place | Chicago, ...
Read More

New Health Canada Licences: Quantum Blue® Infliximab Assay, IBDoc®,CALEX® Cap

BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that three of its novel products, ...
Read More

BUHLMANN Highlights: GanglioCombi™ MAG ELISA

BÜHLMANN GanglioCombi™ MAG ELISA is for Research Use Only. Not for use in diagnostic procedures. BÜHLMANN GanglioCombi™ MAG ELISA Comprehensive ...
Read More

The Value of Calprotectin in Inflammatory Bowel Disease Monitoring

Calprotectin: The Key to a Successful Treatment Pathway for IBD What is Inflammatory Bowel Disease? Inflammatory Bowel Disease (IBD) is ...
Read More

BUHLMANN LabSense News: Winter 2017 Edition

BUHLMANN Diagnostics Corp is proud to release the second edition of our newsletter. View the latest information, new happenings, products ...
Read More

Quantum Blue® Infliximab Assay Highlights

US: BÜHLMANN Quantum Blue® Infliximab is for Research Use Only in the US. Not to be used in diagnostic procedures ...
Read More
Sign Up for BUHLMANN Updates!

Enter your email and stay on top of things,